I concur. The CHF trial results are either going to make or break MSB. If they are not impressive, then being the only results to date from a phase 3 study the science of MSB will be under severe question for the rest of the portfolio of treatments, and holders will simply bail out. The SP will plummet and there'll be no way they'll be able to raise funds again like they just have. With the parlous financial state MSB is in, I can't see them recovering if CHF doesn't carry the flag for them. All should be revealed within days.
Interim CHF data....What will it mean, page-18
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |